Business Wire

Impartner Launches HyperscalerGTM, the First Unified Partner-to-Marketplace Automation

Share

Impartner, the global leader in partner management and partner marketing automation, today announced the launch of HyperscalerGTM, a disruptive new solution that unifies the entire partner-to-cloud-marketplace journey.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015648514/en/

The launch of HyperscalerGTM represents the most significant advancement in partner automation in a decade, introducing a disruptive solution that unifies the entire partner-to-cloud-marketplace journey.

For the first time ever, vendors can enable partners to register deals, collaborate with hyperscaler field teams, and transact directly in cloud marketplaces all from within a single, automated workflow. The result is a faster, simpler path from partner registration to closed marketplace revenue.

“HyperscalerGTM is the most significant advancement in partner automation in a decade,” said Joe Wang, CEO of Impartner. "By integrating the deal registration process directly into hyperscaler marketplace transactions, we're giving vendors and their partners the ability to move opportunities from registration to revenue faster than ever before."

Developed in partnership and with technological support from Labra, the multi-cloud GTM acceleration and AWS Advanced Technology Partner, HyperscalerGTM connects Impartner’s industry-leading PRM with Labra’s native marketplace automation engine. This integration streamlines co-sell workflows, automates private offers, and synchronizes revenue data across AWS, Microsoft Azure, and Google Cloud Platform giving enterprises a unified view of every deal from registration to payout.

“This collaboration bridges the long-standing divide between channel, alliance, and hyperscaler motions,” said Sridhar Adusumilli, CEO at Labra. “Together, we’re helping vendors and partners cut deal-to-marketplace cycles by more than half, capture greater hyperscaler incentives, and eliminate the manual steps that slow cloud growth.”

This launch marks the latest milestone in Impartner’s mission to redefine partner experience and ecosystem monetization in the cloud era, allowing companies to fully realize the opportunities within cloud marketplaces.

HyperscalerGTM will be available on a subscription model with a base fee, plus transaction-based pricing that scales with adoption and growth. The new solution is available today as part of Impartner’s early release window, with general availability beginning in November.

To learn more or schedule a demo, visit: impartner.com/hyperscalergtm

About Impartner

Impartner is the global leader in partner ecosystem management solutions, helping companies transform how they engage, enable, and grow their partner networks. With purpose-built technologies for partner relationship management (PRM) and partner marketing automation (PMA), Impartner empowers organizations to streamline operations, drive demand, and accelerate revenue by delivering measurable ROI from channel programs. Millions of partners across the globe rely on Impartner daily, making it the most widely adopted PRM platform in the world. From onboarding and guided journeys to performance insights and business planning, Impartner delivers automation and best practices that scale. Learn more at impartner.com.

About Labra

Labra is a multi-cloud GTM acceleration platform and AWS Advanced Technology Partner that helps companies scale revenue across AWS, Microsoft Azure, and Google Cloud marketplaces. Labra’s automation engine simplifies marketplace listings, private offers, and co-sell execution, enabling frictionless transactions and faster time to revenue for software vendors and partners worldwide. Learn more at labra.io.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251015648514/en/

Contacts

For media inquiries, please contact:
Lola Phonpadith
Lola.phonpadith@impartner.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release

Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou

SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release

SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ

Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release

Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl

GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c

BitGo yn Sicrhau Cymeradwyaeth OCC i Drosi i Fanc Ymddiriedolaeth Genedlaethol Siartredig Ffederal13.12.2025 02:13:00 CET | Pressmeddelande

Cyhoeddodd BitGo Holdings, Inc. (“BitGo”), y cwmni seilwaith asedau digidol, heddiw fod Swyddfa Rheolwr yr Arian Cyfred (“OCC”) wedi cymeradwyo ei gais i drosi BitGo Trust Company, Inc., cwmni ymddiriedolaeth siartredig De Dakota, i fanc cenedlaethol o'r enw BitGo Bank & Trust, National Association (N.A.). Gyda chymeradwyaeth OCC heddiw o'i drosi, mae is-gwmni Cwmni Ymddiriedolaeth BitGo bellach yn gweithredu fel BitGo Bank & Trust, National Association (N.A.). Bydd BitGo Bank & Trust, N.A. yn gweithredu o dan un gyfundrefn oruchwylio ffederal unffurf, gan ei alluogi i ddarparu'r eglurder, y llywodraethiant, a'r sicrwydd rheoleiddiol y mae sefydliadau'n eu disgwyl gan ymddiriedolwr a reoleiddir yn ffederal. Mae'r gymeradwyaeth hon yn atgyfnerthu safle BitGo fel sylfaen sefydliadol ar gyfer y system ariannol fodern, gan gyfuno goruchwyliaeth ar lefel banc â'r diogelwch, y cydymffurfiaeth, a'r graddadwyedd sy'n diffinio seilwaith BitGo. O dan siarter y banc cenedlaethol, ac yn amodol ar

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye